Preferences help
enabled [disable] Abstract
Number of results
2013 | 3 | 2 | 119-128
Article title

Zaburzenia psychiczne u chorych na nowotwory – podejście kliniczne

Title variants
Mental disorders in cancer patients – clinical approach
Languages of publication
Cancer patient is struggling not only with the primary disease, but also is exposed to emotional states that at unfavorable conditions and heavy burden can lead to depression, increased anxiety, and in consequence cause various mental disorders. Good cooperation between the medical oncologist and the patient, as well as medical oncologist with a psychiatrist and/or psychotherapist can help in the correct diagnosis of these disorders and the implementation of treatment tailored to the patient’s general state and the severity of these symptoms. The paper presents background information on depression and anxiety in cancer patients as well as treatment options.
Pacjent z chorobą nowotworową nie tylko mierzy się z chorobą pierwotną, ale także narażony jest na stany emocjonalne, które przy niesprzyjających warunkach i dużym obciążeniu mogą prowadzić do depresji, zwiększonego lęku i w konsekwencji do różnych zaburzeń psychicznych. Dobra współpraca lekarza onkologa z pacjentem, a także lekarza onkologa z psychiatrą i/lub psychoterapeutą może pomóc we właściwej diagnozie tych zaburzeń i wdrożeniu leczenia dopasowanego do stanu chorego i nasilenia tych objawów. Praca przedstawia ogólne informacje nt. depresji i lęku w chorobie nowotworowej, jak również możliwości terapii.

Physical description
  • Holland J.C., Rowland J.H.: Handbook of Psychooncology. Oxford University Press, New York 1998.
  • Ducrocq F., Vaiva G., Cottencin O., Molenda S., Bailly D.: Post-traumatic stress, post-traumatic depression and major depressive episode: literature. Encephale 2001; 27(2): 159-68.
  • Smith M.Y., Redd W.H., Peyser C., Vogl D.: Post-traumatic stress disorder in cancer: a review. Psycho-Oncology 1999; 8(6): 521-537.
  • Alderfer M.A., Navsaria N., Kazak A.E.: Family functioning and posttraumatic stress disorder in adolescent survivors of childhood cancer. J. Fam. Psychol. 2009; 23(5): 717-25.
  • Naderi M., Firouzkoohi Moghadam M., Hamzenejad M., Emamdadi A., Karami H.: Post-traumatic stress disorder and related factors in parents of children with cancer in South-East of Iran. Iran Red Crescent. Med. J., 2012; 14(12): 776-81.
  • Carney R., Freedland K. Miller G., Jaffe A.: Depression as a risk factor for cardiac mortality and morbidity. A review of potential mechanisms. J. Psychosom. Res. 2002; 53: 897-902.
  • Rudisch B., Nemeroff C.: Epidemiology of comorbid coronary artery disease and depression. Biol. Psychiatry 2003; 54: 227-240.
  • Ziółkowska-Kochan M., Pracka D.: Depresja po udarze mózgu. Psychiatria w Praktyce Ogólnolekarskiej 2003; 3(4): 203-208.
  • Wichowicz H.M., Sławek J., Derejko M. et al.: Factors associated with depression in Parkinson‘s disease: a cross-sectional study in a Polish population. Eur. Psychiatry 2006; 21: 516-520.
  • Nowicki A., Rządkowska B.: Depresja i lęk u chorych z nowotworami złośliwymi. Współ. Onkol. 2005; 9(9): 396-403.
  • Potyralska M.M., Krawczyk A.M.: Depresja u osób z cukrzycą typu 2 – współwystępowanie, implikacje kliniczne i terapeutyczne. Wiad. Lek. 2007; 60(9-10): 449-453.
  • Krzyżanowski J.: Depresja. Wydawnictwo Medyk Sp. z o.o., Warszawa 2002: 19.
  • Gupta S., Saha P.K., Mukhopadhyay A.: Prevalence of hypothyroidism and importance of cholesterol estimation in patients suffering from major depressive disorder. J. Indian. Med. Assoc. 2008; 106: 240-242.
  • Bergevin P., Bergevin R.: Recognising depression. Am. J. Hospice Pall. Care 1995; 12: 22-3.
  • Pyter L.M., Pineros V., Galang J.A. et al.: Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamicpituitary-adrenal axis regulation. Proc. Natl. Acad. Sci. USA 2009; 106: 9069-9074.
  • Block S.D.: Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians – American Society of Internal Medicine. Ann. Intern. Med. 2000; 132(3): 209-218.
  • Kieszkowska-Grudny A.: Dystres i depresja u chorych na nowotwory – diagnostyka i leczenie. Oncoreview 2012; 4(8): 246-251.
  • Wise M.G., Rundell J.: The American Psychiatric Publishing Textbook of Consultation-Liaison Psychiatry: Psychiatry in the Medically Ill. American Psychiatric Pub. 2002: 1160.
  • Roth A.J., Holland J.C.: Psychiatric complications in cancer patients. W: Current Therapy in Hematology-Oncology. 5th ed. Brain M.C., Carbone P.P. (red.), Mosby-Year Book, Inc. St. Louis, Mo 1995: 609-18.
  • Richelson E.: Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs. Mayo Clin. Proc. 1997; 72(9): 835-47.
  • Preskorn S.H.: Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism. Clin. Pharmacokinet. 1997; 32(supl. 1): 1-21.
  • Jin Y., Desta Z., Stearns V. et al.: CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J. Natl. Cancer. Inst. 2005; 97(1): 30-9.
  • Grassi L., Riba M.: W: Depressive Disorders in Physical Illness. Riba M., Grassi L. (red.). World Psychiatric Association, Geneve 2008; 67-81,200.
  • Li M., Fitzgerald P., Rodin G.: Evidence-based treatment of depression in patients with cancer. J. Clin. Oncol. 2012; 30(11): 1187-96.
  • Kieszkowska-Grudny A., Grudny J., Sierko E. et al.: Role of psychological and emotional factors in cancer related fatigue (CRF) syndrome in advanced NSCLC patients undergoing palliative chemotherapy. Advances in Palliative Medicine 2010; 9: 81-86.
  • Stark D., Kiely M., Smith A., Velikova G., House A., Selby P.: Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J. Clin. Oncol. 2002; 20(14): 3137-48.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.